Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). (Q35597885)
Jump to navigation
Jump to search
scientific article published on 12 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). |
scientific article published on 12 October 2011 |
Statements
1 reference
Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). (English)
1 reference
John P Bilezikian
1 reference
Dennis M Black
1 reference
Ann V Schwartz
1 reference
Anne L Schafer
1 reference
Deborah E Sellmeyer
1 reference
Clifford J Rosen
1 reference
Lisa Palermo
1 reference
Dolores M Shoback
1 reference
12 October 2011
1 reference
1 reference
Identifiers
1 reference